Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial
PaperCitations, authors & open-access status
Targeted-release budesonide modifies key pathogenic biomarkers in immunoglobulin A nephropathy: insights from the NEFIGAN trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 55 citations, 2023 year and hybrid oa status.
55
Citations
2023
Year
hybrid
OA Status